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Poster Session II 161or cord blood unit. The form is completed when a formal search is
initiated, then every 2 weeks.
3) Donor selection and workup phase: The form contains a de-
scription of the donor workup process, details of the selected donor,
and transplant plan. This is completed at the time the donor workup
request is submitted and when a transplant date has been estab-
lished.
Once the update form is completed by the search coordinator, it
is faxed to the referring physician’s office. Each form contains the
name and contact number of the coordinator managing the search
if needed. Results: An informal survey of referring physicias and
nursing staff demonstrates a positive response to the update format.
Based on this feedback, a user friendly and well defined process to
update referring physicians regarding the progress of identifying
a suitably matched unrelated donor or cord blood unit has been suc-
cessfully implemented at a large volume transplant center.454
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In recent years, numerous advances in the field of Stem Cell
Transplantation and Cellular Therapy (SCTCT) have been made
in treating a variety of cancers and nonmalignant conditions in chil-
dren. One such novel treatment approach in this patient population
has been the infusion of two cord blood units following condition-
ing with chemotherapy and immune modulating drugs. With this
advancement has come the need to educate healthcare providers re-
sponsible for the care of patients undergoing this form of transplan-
tation in order to enhance their patient care skills.
Nurses have played an indispensable role in caring for these pa-
tients during all phases of the transplantation process. From the ini-
tial patient work-up to the time a patient is transferred back to their
home clinic, a variety of nurses have several roles and responsibili-
ties which allow for seamless care and optimal patient outcomes. Al-
though many policies and procedures related to double cord blood
transplants parallel those associated with other types of transplants,
there are some unique challenges and opportunities in this setting of
which nurses should be aware.
Using patient examples we will highlight the key points relating
to nursing care of pediatric patients undergoing double cord blood
transplants. Advantages and disadvantages of double cord blood
transplants will be summarized and compared to other methods
of transplantation. Additionally, we will present practice standards
developed specifically to address some of the unique clinical chal-
lenges seen in these patients during the post-transplant period. Fol-
lowing our presentation, nurses are expected to have a broader
understanding of the biology and patient care needs of double
cord blood recipients as well as the potential for reductions in hos-
pitalization duration, overall costs and morbidity during the post-
engraftment period.455
A PRACTICAL TOOL FOR NEWLY SPECIALIZING NURSES
Hogan, M.B. Barnes-Jewish Hospital, St. Louis, MO.
Equipped with three months of training and a voluminous binder,
new nurses to BMT traditionally have reported approximately two
years of trial and error in their practice before feeling confident
about their care. A vast specialized knowledge is required immedi-
ately for new nurses’ practice, particularly night nurses who are re-
sponsible for treating labs drawn by day shift—usually according to
standing orders, contacting physicians to adjust treatments based ondrug levels, checking chemotherapy orders and giving first doses,
and reviewing 24 hours worth of orders for accuracy and consis-
tency to the computer system.
To address new nurses’ frustrations, a critical thinking tool was
developed on the standard orders. The goal was two–fold: nurses
learn the standing orders and bridge gaps between their nursing
knowledge bases, specifics to BMT, considerations for each order
from rationale and expected effects to observed side effects and con-
traindications for which to assess before carrying out orders. Some
orders lay out algorithms, like those found on crash carts. Precep-
tors spend approximately one week working in–depth on each
page with the new nurses and review the entirety numerous times
throughout orientation.
Four new nurses were given this teaching tool; two of the nurses
were new graduates, one had a year nursing experience, and one is in
orientation currently. Anecdotal evidence has been compelling. The
three nurses who successfully completed orientation reported the
tool was the first, easiest reference they sought before contacting
the on–call physician or even questioning another nurse, and they
pocketed the tool during their shifts. Each nurse discovered addi-
tional questions, for instance, the implications of radiological tests
and often–ordered cardiac enzymes. Therefore, the tool is con-
stantly changing to reflect their needs and similar conjuntive tools
are being developed, one entitled ‘‘Drips.’’ Additionally, ten veteran
nurses requested copies to improve their practice.456
NURSING GUIDELINES FOR THE MANAGEMENT OF STEM CELL TRANS-
PLANT PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
Babino, E.M.G., Estrella, J.M.E. UTMDCancer Center, Houston, TX.
Topic/Background: : Stem Cell Transplant (SCT) patients are
faced with rigorous challenges throughout the transplant process
as a result of chemotherapy regimen, prolonged state of neutropenia
and complications brought about by the transplant itself. One com-
plication that has been observed after SCT is Thrombotic Throm-
bocytopenic Purpura (TTP), also known as Hemolytic Uremic
Syndrome (HUS). Purpose: The purpose of this abstract to de-
velop nursing guidelines in the care of SCT patients with TTP/
HUS. The tool will present nursing assessment, monitoring of
symptoms, diagnostic exams, interventions, management and eval-
uation of treatment. Discussion/Intervention: Reports suggest
about 13% of SCT patients may develop TTP/HUS and those
with prolonged thrombocytopenia, infections, and graft-versus-
host-disease (GVHD) are placed at a higher risk (Sawant & Rajad-
hyaksha, 2005). TTP/HUS is a complex syndrome of vascular
endothelial injury and platelet thrombus formation within micro-
vasculature that may lead to ischemia of the brain, kidney or heart,
and may even result to death. The SCT nurse plays an important
role in the recovery of patients in the acute care setting through clin-
ical knowledge of the disease process, identification of symptoms,
critical laboratory values, timely interventions and efficient man-
agement of complications. Implication to Nursing: Due to the
complexity of care of SCT patients and the seriousness of TTP/
HUS as a post transplant complication, communication and collab-
oration between the bedside nurse and the primary team are highly
essential. In addition to conventional supportive treatments and
monitoring of pertinent laboratory values, timing and immediate
initiation of plasma exchange is crucial. Evaluation: This poster
presentation will include a case study of a patient manifesting the
classic symptoms of TTP/HUS and the nursing guidelines to assist
the SCT nurse in providing the appropriate care.457
ZAP THAT ENERGY BACK: ENGAGING THE STEM CELL TRANSPLANT PA-
TIENT IN TERTIARY ACTIVITIES
Estrella, J.M.E., Granada, M.L.A. UT MD Anderson Cancer Center,
Houston, TX.
Topic/Background: Myeloablative and non-myeloablative regi-
mens have led to increased patient eligibility for Stem Cell
